NCT01027845 - Primary and Booster Vaccination Study With Pneumococcal Vaccine GSK1024850A in Healthy Japanese Children | Biotech Hunter

Enrollment

360

Participants

Timeline

Start Date

December 8, 2009

Primary Completion Date

August 13, 2010

Study Completion Date

September 17, 2011

Conditions

Infections, Streptococcal

Interventions

BIOLOGICAL

Pneumococcal vaccine GSK1024850A

Intramuscular injection, 4 doses

BIOLOGICAL

DTPa

Subcutaneous injection, 4 doses

Trial Locations (16)

451-0052

GSK Investigational Site, Aichi

299-4503

GSK Investigational Site, Chiba

720-8520

GSK Investigational Site, Hiroshima

730-8562

GSK Investigational Site, Hiroshima

003-0021

GSK Investigational Site, Hokkaido

765-8501

GSK Investigational Site, Kagawa

238-8567

GSK Investigational Site, Kanagawa

243-8551

GSK Investigational Site, Kanagawa

247-8533

GSK Investigational Site, Kanagawa

856-8562

GSK Investigational Site, Nagasaki

957-8588

GSK Investigational Site, Niigata

701-0205

GSK Investigational Site, Okayama

555-0001

GSK Investigational Site, Osaka

560-0004

GSK Investigational Site, Osaka

591-8025

GSK Investigational Site, Osaka

152-0021

GSK Investigational Site, Tokyo